It looks like you're accessing our website from North America. We have a dedicated page tailored to your region, offering the most relevant information and services.
If you have an existing eCom account, you can log in to the North American site using your current username and password.
Would you like to visit the North America page?
You can access the page here
If you have any questions, please feel free to contact our support team hytest@hytest.fi
BNP and NT-proBNP are widely used biomarkers of
heart failure. However, obesity influences the concentrations of these
markers in circulation, and unfortunately the underlying reasons for
this are not well understood. In practice it currently means that the
clinical utility of these biomarkers is limited if the patient is obese.
Now Lewis et al. have addressed this understudied topic related to
interrelationship between obesity and BNP/NT-proBNP.
Read the editorial and listen to the accompanying podcast for an interview with Dr. Semenov.
Copyright © 2025 Hytest Ltd.